Comparing Claritin-D vs Mucinex D
| Claritin-D (loratadine / pseudoephedrine) | Mucinex D (guaifenesin / pseudoephedrine) |
|
|---|
| Claritin-D (loratadine / pseudoephedrine) | Mucinex D (guaifenesin / pseudoephedrine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Over-the-counter
Prescribed for Nasal Congestion, Allergic Rhinitis. Claritin-D may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Cough and Nasal Congestion. Mucinex D may also be used for purposes not listed in this medication guide. |
||||||||
| More about Claritin-D (loratadine / pseudoephedrine) | More about Mucinex D (guaifenesin / pseudoephedrine) | ||||||||
| Ratings & Reviews | |||||||||
|
Claritin-D has an average rating of 5.5 out of 10 from a total of 72 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 38% reported a negative effect. |
Mucinex D has an average rating of 6.1 out of 10 from a total of 224 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Claritin-D side effects |
View all Mucinex D side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Mucinex D prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other loratadine / pseudoephedrine brands include: Alavert D-12 Hour Allergy and Sinus, AllerClear D-24 Hour, Allergy & Congestion Relief, Allergy Relief D 24 Hour, Allergy Relief D12, Claritin-D 12 Hour, Claritin-D 24 Hour, Clear-Atadine-D, Leader Allergy Relief D-24, Loratadine-D 12 Hour, Loratadine-D 24 Hour View more | Other guaifenesin / pseudoephedrine brands include: Aldex GS, Altarussin PE, Ambi 60/1000, Ambi 60/580, Ambi 80/780, Ambifed, Ambifed-G, Ami-Tex PSE, Anatuss LA, Aquatab D Dose Pack, Coldmist, Coldmist Jr, Coldmist LA, Congestac, D-Feda II, Deco-D, Decongest II, Deconsal LA, Defen-LA, Degen II, Demibid II, Desal II, Despec-SR, Despec-Tab, Drituss GP, Durasal II, Duratuss GP (old formulation), Dynex, Entex PSE, Entex T, Eudal SR, ExeFen, ExeFen-IR, Fenex-PSE, G-Phed, G-Phed- PD, GP 500, Guai Sudo, Guai-Vent/PSE, Guaibid D, Guaibid D Pediatric, Guaifed, Guaifed-PSE, Guaifenex GP, Guaifenex PSE 120, Guaifenex PSE 60, Guaifenex PSE 80, Guaifenex PSE 85, Guaifenex RX, Guaimax-D, Guaipax PSE, Guaitab, Guaivent (Ethex), Guaivent PD, Guiadrine II, Guiadrine II SR, Guiadrine PSE, Guiadrine PSE 120, Guiatex II, Guiatex II SR, Guiatex PSE, Guiatuss PE, Humibid GC, Mardrops-EX, Maxifed, Mucinex D Maximum Strength, Mucus D, Mucus Relief D, Nalex CR, Nalex Jr, Poly-Vent IR, Robitussin Severe Congestion, Ru-Tuss DE, Sinutab Non Drying, Tusnel Pediatric Drops View more | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
18 hours |
16 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 328 drugs are known to interact with Claritin-D:
|
A total of 220 drugs are known to interact with Mucinex D:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 14, 1994 |
June 22, 2004 |
||||||||
| WADA Class View classifications | |||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.